<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>97(6)</volume><submitter>de Oliveira KG</submitter><funding>This study was supported by PROADI_SUS.</funding><pubmed_abstract>Hepatitis A Virus (HAV) infects millions of individuals annually and is a major cause of acute viral hepatitis worldwide. This study aims to (1) assess HAV infection in suspected acute hepatitis patients at public healthcare institutions in Brazil; (2) evaluate the proportion of immunized individuals against HAV; (3) identify HAV genotypes; (4) examine the association between HAV infection and demographic data, as well as exposure to risk factors. This is a prospective, observational multicenter study conducted in primary health services in Brazil from October 2019 to May 2023, involving 1721 patients with suspected acute hepatitis. Acute HAV infection was identified in 108 (6.3%) patients, predominantly in young men (80%) and from South and Southeast regions of Brazil (97%). Anti-HAV IgG,</pubmed_abstract><journal>Journal of medical virology</journal><pagination>e70449</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12175488</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Comprehensive Molecular and Serological Investigation of Hepatitis A Virus Among Patients With Suspected Acute Hepatitis: A Brazilian Study.</pubmed_title><pmcid>PMC12175488</pmcid><pubmed_authors>de Oliveira GSS</pubmed_authors><pubmed_authors>Gonzalez MP</pubmed_authors><pubmed_authors>Tenore S</pubmed_authors><pubmed_authors>Parana R</pubmed_authors><pubmed_authors>Nastri ACSS</pubmed_authors><pubmed_authors>Coral GP</pubmed_authors><pubmed_authors>Gurski APM</pubmed_authors><pubmed_authors>Vasconcelos MPA</pubmed_authors><pubmed_authors>Casadio LVB</pubmed_authors><pubmed_authors>Siqueira RA</pubmed_authors><pubmed_authors>Lopes EPA</pubmed_authors><pubmed_authors>Fanis BEA</pubmed_authors><pubmed_authors>Castberg L</pubmed_authors><pubmed_authors>Schinoni MI</pubmed_authors><pubmed_authors>Carrilho FJ</pubmed_authors><pubmed_authors>Lucena M</pubmed_authors><pubmed_authors>Guedes MDC</pubmed_authors><pubmed_authors>Alvares-da-Silva MR</pubmed_authors><pubmed_authors>Pinto AS</pubmed_authors><pubmed_authors>Maluf MM</pubmed_authors><pubmed_authors>Emerim E</pubmed_authors><pubmed_authors>Ornelas Pereira Salvador de Oliveira D</pubmed_authors><pubmed_authors>de Mello Malta F</pubmed_authors><pubmed_authors>Acosta PR</pubmed_authors><pubmed_authors>Ferreira PRA</pubmed_authors><pubmed_authors>Domingues TSP</pubmed_authors><pubmed_authors>Mendes-Correa MCJ</pubmed_authors><pubmed_authors>Uehara SNO</pubmed_authors><pubmed_authors>Ximenez LL</pubmed_authors><pubmed_authors>Inoue CA</pubmed_authors><pubmed_authors>Gdalevici C</pubmed_authors><pubmed_authors>Amgarten D</pubmed_authors><pubmed_authors>Villar LM</pubmed_authors><pubmed_authors>Dorlass E</pubmed_authors><pubmed_authors>Salomao A</pubmed_authors><pubmed_authors>Pimenta MC</pubmed_authors><pubmed_authors>Garcia RFL</pubmed_authors><pubmed_authors>Nascimento-Sales M</pubmed_authors><pubmed_authors>de Almeida EC</pubmed_authors><pubmed_authors>de Souza FMA</pubmed_authors><pubmed_authors>Bertolini DA</pubmed_authors><pubmed_authors>de Azevedo RS</pubmed_authors><pubmed_authors>Luiz MC</pubmed_authors><pubmed_authors>Munoz Torres PA</pubmed_authors><pubmed_authors>Gomes-Gouvea MS</pubmed_authors><pubmed_authors>Souza FF</pubmed_authors><pubmed_authors>Pereira GFM</pubmed_authors><pubmed_authors>Hyppolito E</pubmed_authors><pubmed_authors>Ferreira A</pubmed_authors><pubmed_authors>Sitnik R</pubmed_authors><pubmed_authors>Selegatto G</pubmed_authors><pubmed_authors>de Oliveira KG</pubmed_authors><pubmed_authors>Pinho JRR</pubmed_authors><pubmed_authors>Panico CT</pubmed_authors><pubmed_authors>Souto F</pubmed_authors><pubmed_authors>Ferraz MLG</pubmed_authors><pubmed_authors>Arrojo RS</pubmed_authors><pubmed_authors>Ton JT</pubmed_authors><pubmed_authors>Robinson PJ</pubmed_authors><pubmed_authors>Leite OHM</pubmed_authors><pubmed_authors>Teixeira R</pubmed_authors><pubmed_authors>Lobato CMDO</pubmed_authors><pubmed_authors>Sebe P</pubmed_authors><pubmed_authors>Reuter T</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Comprehensive Molecular and Serological Investigation of Hepatitis A Virus Among Patients With Suspected Acute Hepatitis: A Brazilian Study.</name><description>Hepatitis A Virus (HAV) infects millions of individuals annually and is a major cause of acute viral hepatitis worldwide. This study aims to (1) assess HAV infection in suspected acute hepatitis patients at public healthcare institutions in Brazil; (2) evaluate the proportion of immunized individuals against HAV; (3) identify HAV genotypes; (4) examine the association between HAV infection and demographic data, as well as exposure to risk factors. This is a prospective, observational multicenter study conducted in primary health services in Brazil from October 2019 to May 2023, involving 1721 patients with suspected acute hepatitis. Acute HAV infection was identified in 108 (6.3%) patients, predominantly in young men (80%) and from South and Southeast regions of Brazil (97%). Anti-HAV IgG,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-02T00:31:14.84Z</modification><creation>2026-05-24T03:07:13.432Z</creation></dates><accession>S-EPMC12175488</accession><cross_references><pubmed>40530670</pubmed><doi>10.1002/jmv.70449</doi></cross_references></HashMap>